2nd Quarter - Report — MEDSECUREAN.COM for INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY… (2026)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

MEDSECUREAN.COM

Client

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

Income

$900,000

Expenses

—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report (this page)	Jul 13, 2026	$900,000	Replaced
2nd Quarter - Amendment	Jul 13, 2026	$90,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

National Security - Medicine Security Health Care Transparency Generics First Generic Market Sustainability Affordable Medicine Partership Trade

Foreign entity interest: The Indian Pharmaceutical Alliance (IPA) is an Indian trade association representing leading multinational pharmaceutical companies, many of which maintain a significant physical and commercial presence in the United States through their North American subsidiaries. As essential partners in Americas medicine supply chain, IPA member companies manufacture nearly 50 percent of the affordable medicines used by patients in the United States. IPA and its members seek to deepen their partnership with the U.S. government and industry to strengthen health and medicine security in both the United States and India, reduce dependence on countries of concern, and build more secure, diversified, and resilient pharmaceutical supply chains. U.S. invited IPA members to two Round Tables at USASelect to discuss working together to reshore affordable medicine and inputs and to discuss U.S. market reforms to drive onshoring.

Lobbyist	Covered position, as disclosed
KATHLEEN JAEGER	—

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); White House Office; SENATE; U.S. Trade Representative (USTR); Bureau of Industry and Security (BIS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Trade (domestic/foreign) TRD

U.S. - India Affordable Medicine Patnership

Foreign entity interest: The Indian Pharmaceutical Alliance (IPA) is an Indian trade association representing leading multinational pharmaceutical companies, many of which maintain a significant physical and commercial presence in the United States through their North American subsidiaries. As essential partners in Americas medicine supply chain, IPA member companies manufacture nearly 50 percent of the affordable medicines used by patients in the United States. IPA and its members seek to deepen their partnership with the U.S. government and industry to strengthen health and medicine security in both the United States and India, reduce dependence on countries of concern, and build more secure, diversified, and resilient pharmaceutical supply chains. At the request of the U.S. government, IPA discussed US-India Affordable Partnership during two different round tables set up by the U.S. government.

Lobbyist	Covered position, as disclosed
KATHLEEN JAEGER	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.